UBS Equities-China Equity Strategy _Crowded trades The next beneficiarie...-107450855
Global Research and Evidence Lab Crowded trades: The next beneficiaries—the what, the where and the why
报告摘要
Global Research and Evidence Lab Crowded trades: The next beneficiaries—the what, the where and the why
报告信息
- 文件全名
- 《UBS Equities-China Equity Strategy _Crowded trades The next beneficiarie...-107450855.pdf》
- 适合读者
- 核心数据
- 600028.SS Sinopec - A 109,362 17% -1% 9.1 002371.SZ NAURA Technology 21,809 39% 32% 22.0
- 600900.SS Yangtze Power 82,647 22% 9% 15.8 688111.SS Kingsoft Office 18,186 28% 36% 56.7
- 601816.SS Beijing-Shanghai HSR 34,545 17% 9% 17.2 000921.SZ Hisense H.A. 6,059 20% 15% 11.4
- 601319.SS PICC Group - A 32,271 12% 10% 8.3 000423.SZ Dong-E E-Jiao 5,682 20% 18% 25.5
- 601766.SS CRRC Corp - A 27,368 12% 14% 14.2 300674.SZ Yusys 1,301 27% 36% 16.3
- 核心议题
常见问题
《UBS Equities-China Equity Strategy _Crowded trades The next beneficiarie...-107450855》主要包含哪些内容?
Global Research and Evidence Lab Crowded trades: The next beneficiaries—the what, the where and the why核心数据:600028.SS Sinopec - A 109,362 17% -1% 9.1 002371.SZ NAURA Technology 21,809 39% 32% 22.0;600900.SS Yangtze Power 82,647 22% 9% 15.8 688111.SS Kingsoft Office 18,186 28% 36% 56.7;601816.SS Beijing-Shanghai HSR 34,545 17% 9% 17.2 000921.SZ Hisense H.A. 6,059 20% 15% 11.4。
这份报告覆盖哪一年、篇幅多大?
覆盖 2024 年,全文约 22。
这份报告是免费的吗?如何获取?
本报告免费查阅,登录资料宝后即可在线获取完整内容。
这份报告适合哪些读者?
适合战略规划、行业研究员等读者参考。
报告涉及哪些关键议题?
重点分析了管理咨询等议题。
继续阅读
查看全部 →